CAG · Q3 2026 Earnings

Q4 anchor: margin-for-volume doctrine → Q1 anchor: "consumer not out of the woods" → Q2 anchor: active management and Project Catalyst optionality → Q3 anchor: "responsive to the hand we are dealt" + concrete margin recovery building blocks.

The pricing posture has fully inverted from the Q4 FY2025 doctrine. Three quarters ago management framed broad-based pricing as the problem ("relentless pricing actions… lead to protracted volume declines") and committed to "investing margin this year in the service of volume." This quarter management said: "we did take pricing this year on a bunch of products, our canned foods and our cocoa-oriented products, and the elasticities have been quite encouraging." The shift signals that selective pricing — what the company calls "horses for courses" — is now positioned as a permanent operating capability, not a temporary fallback, and Q3's +1.9% price/mix is the data point validating the framing.

Margin recovery moved from deferred-to-FY27 to actively-engineered-now. In Q4 FY2025 management framed FY26 as the absorption year and FY27 as the payoff; in Q1 they reinforced that horizon; in Q2 they introduced Project Catalyst as the FY27 lever with all quantification deferred. This quarter the framing tightened to: "we absolutely, you know, assuming we can get some element of normalcy, we absolutely expect margin expansion going forward, particularly in frozen." The anchor signals that margin recovery is no longer a single-lever story (Catalyst) but a multi-lever one (productivity, selective pricing, supply chain repatriation, inventory reduction) — yet the FY26 operating margin guide still requires a Q4 print well above the 10.6% Q3 actual, so the building blocks have to compound fast.

Supply chain shifted from defensive narrative to offensive capability. The Q1 framing was 98% service recovery as competitive advantage; this quarter management quantified the forward economics: "the advancement of our supply chain resiliency investments, including the chicken plants… is going to enable us at some point to repatriate outsourced volume, which will be a good guy for margin." The shift means the FY27 margin bridge now has a specific operational mechanism — outsource-to-insource gross-margin recapture — that wasn't articulated in prior quarters.

The volume framing introduced a new and unusually candid metaphor. Management called the cycle "a volume sabbatical rather than… a permanent volume rebase." Across the prior three quarters volume losses were attributed alternately to supply disruption, consumer value-seeking, and pricing-elasticity normalization. The "sabbatical" framing is a stronger conviction statement — management is publicly committing to the view that volumes return, which raises the cost of being wrong if Q4 organic decelerates.

The FY27 outlook turned more hedged, not less. Last quarter Project Catalyst was the optimistic anchor; this quarter management repeatedly deferred FY27 specifics: "It's too early to speculate on a particular course of action," "There's three and a half months to go before we guide for fiscal 27," and "we don't have line of sight to that at this time." The hedging is concentrated on tariff wrap (now sized at ~$40M for FY27 vs the original $80M estimate, a favorable revision) and protein cost exposure (only ~15% covered for FY27). The cautious posture undercuts the operational confidence elsewhere in the call and is the single biggest reason this print reads cautious despite a clean Q3 operational beat.